Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment
Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment GlobeNewswire November 12, 2025 The notice was received by the China National Intellectual Property Administration Vancouver, Canada, Nov. 12, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel […]